What is PAVmed?
PAVmed Inc. is a commercial-stage medical technology firm established in 2014 and headquartered in New York, New York. The company's product portfolio spans disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its operations are strategically positioned across the medical device, diagnostics, and digital health sectors, aiming to innovate and improve patient care through advanced technological offerings.
How much funding has PAVmed raised?
PAVmed has raised a total of $51.1M across 4 funding rounds:
Debt
$14M
Debt
$150K
Other Financing Round
$7M
Private Equity
$30M
Debt (2019): $14M with participation from Maxim Group LLC
Debt (2020): $150K led by PPP
Other Financing Round (2020): $7M, investors not publicly disclosed
Private Equity (2026): $30M, investors not publicly disclosed
Key Investors in PAVmed
PPP
Public-Private Partnership
Maxim Group LLC
Maxim Group LLC is an investment bank and broker-dealer, often involved in providing capital and advisory services to companies in growth phases, particularly within the healthcare and technology sectors.
What's next for PAVmed?
The substantial enterprise-level capital PAVmed has attracted, particularly the recent strategic investment, signals a strong confidence in its growth trajectory and market potential. This influx of financing is likely to fuel further research and development, expansion of manufacturing capabilities, and broader market penetration for its diverse range of medical technologies. The company's focus on disposable infusion pumps, advanced ablation devices, and vascular access solutions positions it to capitalize on increasing demand for efficient and effective healthcare solutions. PAVmed's strategic financial maneuvers indicate a phase of scaling and market consolidation, aiming to solidify its position as a key player in the medtech industry.
See full PAVmed company page
